(SCHD) Schwab U.S. Dividend Equity - Ratings and Ratios

Exchange: NYSE ARCA • Country: USA • Currency: USD • Type: Etf • ISIN: US8085247976

SCHD: Dividend-paying stocks, Large-cap companies, U.S. equities

The Schwab U.S. Dividend Equity ETF (SCHD) is designed to track an index that focuses on high-dividend-yielding U.S. stocks with a history of consistent dividend payments and strong financial fundamentals relative to their peers. The fund invests at least 90% of its assets in these stocks, providing a concentrated exposure to dividend-paying equities.

By targeting companies with a proven track record of dividend payments and robust financial health, SCHD aims to offer a relatively stable source of income and potentially lower volatility compared to the broader market. The underlying indexs methodology ensures that the constituent stocks are selected based on their financial strength, making it an attractive option for income-seeking investors.

From a technical analysis perspective, SCHD is currently trading at $26.17, with its 20-day and 50-day simple moving averages (SMA) at $26.10 and $26.18, respectively, indicating a relatively stable short-term trend. However, the 200-day SMA at $27.28 suggests that the ETF is currently trading below its longer-term trend. The average true range (ATR) of 0.37 (1.40%) indicates moderate daily price movements.

Using the available technical and fundamental data, a forecast for SCHD can be constructed. Given the current price of $26.17 and the support levels at $25.6 and $25.1, a potential downside risk exists if the ETF breaks below these levels. Conversely, resistance levels at $27.0, $27.6, and $28.2 may cap the upside potential in the short term. With a large AUM of $68.038 billion, SCHD is a liquid and sizable ETF, which can be an attractive feature for investors. Assuming the current dividend yield and payout ratio remain stable, and considering the ETFs history of tracking its underlying index, a potential price target for SCHD could be around $28.50 in the next 6-12 months, representing a 9% increase from current levels.

Additional Sources for SCHD ETF

News: Wall Street Journal | Benzinga | Yahoo Finance
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle

SCHD ETF Overview

Market Cap in USD 70,319m
Category Large Value
TER 0.06%
IPO / Inception 2011-10-20

SCHD ETF Ratings

Growth Rating 61.5
Fundamental -
Dividend Rating 71.9
Rel. Strength -2.61
Analysts -
Fair Price Momentum 27.07 USD
Fair Price DCF -

SCHD Dividends

Dividend Yield 12m 3.84%
Yield on Cost 5y 6.97%
Annual Growth 5y 8.02%
Payout Consistency 93.3%
Payout Ratio %

SCHD Growth Ratios

Growth Correlation 3m -3.4%
Growth Correlation 12m 6.1%
Growth Correlation 5y 84.6%
CAGR 5y 12.54%
CAGR/Max DD 5y 0.74
Sharpe Ratio 12m 0.27
Alpha 0.00
Beta 0.607
Volatility 12.02%
Current Volume 13575.2k
Average Volume 20d 13855.1k
What is the price of SCHD shares?
As of June 17, 2025, the stock is trading at USD 26.92 with a total of 13,575,236 shares traded.
Over the past week, the price has changed by +1.01%, over one month by +1.20%, over three months by -2.85% and over the past year by +8.49%.
Is Schwab U.S. Dividend Equity a good stock to buy?
Yes. Based on ValueRay´s Analyses, Schwab U.S. Dividend Equity (NYSE ARCA:SCHD) is currently (June 2025) a good stock to buy. It has a ValueRay Growth Rating of 61.46 and therefor a clear technical positive rating according to historical growth.
Based on momentum, paid dividends and discounted-cash-flow analyses, the fair value of SCHD is around 27.07 USD . This means that SCHD is currently overvalued and has a potential downside of 0.56%.
Is SCHD a buy, sell or hold?
Schwab U.S. Dividend Equity has no consensus analysts rating.
What are the forecasts for SCHD share price target?
According to our own proprietary Forecast Model, SCHD Schwab U.S. Dividend Equity will be worth about 30.4 in June 2026. The stock is currently trading at 26.92. This means that the stock has a potential upside of +12.74%.
Issuer Target Up/Down from current
Wallstreet Target Price - -
Analysts Target Price - -
ValueRay Target Price 30.4 12.7%